Fingerprint
Dive into the research topics of 'Phase II Study of Copanlisib in Patients with Tumors with PIK3CA Mutations: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1F'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically